Edition:
United States

Kala Pharmaceuticals Inc (KALA.OQ)

KALA.OQ on NASDAQ Stock Exchange Global Select Market

12.46USD
4:00pm EDT
Change (% chg)

$0.12 (+0.97%)
Prev Close
$12.34
Open
$12.32
Day's High
$12.65
Day's Low
$12.32
Volume
24,793
Avg. Vol
48,454
52-wk High
$26.74
52-wk Low
$11.81

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.53 December 19 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.25 1.25 1.25 1.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 3 0.00 0.00 0.00 --
Quarter Ending Dec-18 3 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 --
Year Ending Dec-19 4 19.85 25.00 14.00 --
Earnings (per share)
Quarter Ending Sep-18 3 -0.53 -0.49 -0.59 --
Quarter Ending Dec-18 3 -0.56 -0.49 -0.65 --
Year Ending Dec-18 3 -2.06 -1.91 -2.25 --
Year Ending Dec-19 4 -2.83 -1.95 -3.38 --
LT Growth Rate (%) 1 -82.80 -82.80 -82.80 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 0.00 0.00 0.00 0.00
Quarter Ending Dec-17 0.00 0.00 0.00 0.00
Quarter Ending Sep-17 9.30 0.00 9.30 100.00
Quarter Ending Jun-17 3.10 0.00 3.10 100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 0.00 0.00 0.00 0.00 --
Quarter Ending Dec-18 0.00 0.00 0.00 0.00 --
Year Ending Dec-18 0.00 0.00 0.00 0.00 --
Year Ending Dec-19 19.85 19.85 19.85 19.85 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings